Perrigo | PRGO - Bénéfice Avant Impôts





Bénéfice Avant Impôts Changement Date
AbbVie USD 7.61B 2.04B 2026-06
Abbott USD 2.39B 27M 2026-03
Bayer EUR 321M 2.67B 2026-06
Bristol-Myers Squibb USD 4.99B 1.75B 2026-06
Coherus Biosciences USD -46.35M 90.86M 2025-12
Corcept Therapeutics USD -44.72M 54.62M 2026-03
Dr.Reddys Laboratories INR 5.54B 955M 2026-06
Eli Lilly USD 8.85B 583.8M 2026-03
J&J USD 8.66B 839M 2026-06
Merck USD -3.53B 6.95B 2026-03
Nestle CHF 6.77B 475M 2026-06
Pacira USD 5M 4.43M 2026-03
Perrigo USD 105.4M 513.9M 2026-06
Pfizer USD -653M 5.84B 2026-06
Phibro Animal Health USD 38.62M 1.26M 2025-12
Prestige Brands USD 64.77M 2.96M 2026-03
Reckitt Benckiser GBP 1.54B 73M 2025-06
Sanofi EUR 837M 1.17B 2026-06
Supernus Pharmaceuticals USD -57.65M 51.7M 2026-06
Teva Pharmaceutical Industries USD -455M 1.21B 2026-06
Xeris Pharmaceuticals USD 2.23M 8.85M 2026-03
Zoetis USD 758M 3M 2026-03